Learn More
Enzo Life Sciences PKI (14-22) amide (myristoylated) (0.5 mg) CAS: 201422-03-9

Supplier: Enzo Life Sciences BMLP2100500

PKA inhibitor. Heat-stable protein kinase inhibitor (PKI) peptide sequence (14-22). N-terminus is myristoylated to increase cell membrane permeability. The non-myristoylated version of this peptide is a highly specific inhibitor of cAMP-dependent protein kinase (PKA) with Ki=36 nM. This product is a useful tool for studying PKA in cellular systems. Alternative Name: cAMP dependent protein kinase inhibitor (14 22) amide (myristoylated). Formula: C53H100N20O12. MW: 1209.5. CAS: 201422-03-9. Formulation: Lyophilized. Trifluoroacetate salt. Purity: ≥95% (HPLC). Sequence N-myristoyl-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-NH2. Appearance: Solid. Solubility: Soluble to at least 1mg/ml in water. Long Term Storage: -20°C. Handling: Protect from moisture.
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.